Bremelanotide CAS 189691-06-3

Bremelanotide  CAS 189691-06-3  Chemical Properties

Bremelanotide  CAS 189691-06-3 Chemical Properties,Uses,Production

• Description

Bremelanotide PT141, also known as bumenotide, is a drug used to treat female sexual dysfunction. PT-141 has shown positive results in a phase I clinical trial administered to normal premenopausal women.PT141 regulates sexual desire and response by activating endogenous pathways in the brain, helping premenopausal women with hypoactive sexual desire disorder maintain normal sexual desire.

• Uses
  

Bremelanotide acetate has a cyclic heptapeptide structure. A large number of studies have confirmed that their receptor molecules play an important role in sexual arousal, reducing appetite and catalyzing the synthesis of melanin,which can treat sexual dysfunction, obesity and stimulate the skin to produce melanocortin to resist ultraviolet burns and other diseases. PT-141 is a drug developed by the American company Palatin to treat sexual dysfunction.It has completed Phase III clinical trials and is effective for both male and female patients. It is especially the only effective drug candidate for female patients with frigidity.